Literature DB >> 11520923

alpha-Latrotoxin and its receptors: neurexins and CIRL/latrophilins.

T C Südhof1.   

Abstract

alpha-Latrotoxin, a potent neurotoxin from black widow spider venom, triggers synaptic vesicle exocytosis from presynaptic nerve terminals. alpha-Latrotoxin is a large protein toxin (120 kDa) that contains 22 ankyrin repeats. In stimulating exocytosis, alpha-latrotoxin binds to two distinct families of neuronal cell-surface receptors, neurexins and CLs (Cirl/latrophilins), which probably have a physiological function in synaptic cell adhesion. Binding of alpha-latrotoxin to these receptors does not in itself trigger exocytosis but serves to recruit the toxin to the synapse. Receptor-bound alpha-latrotoxin then inserts into the presynaptic plasma membrane to stimulate exocytosis by two distinct transmitter-specific mechanisms. Exocytosis of classical neurotransmitters (glutamate, GABA, acetylcholine) is induced in a calcium-independent manner by a direct intracellular action of alpha-latrotoxin, while exocytosis of catecholamines requires extracellular calcium. Elucidation of precisely how alpha-latrotoxin works is likely to provide major insight into how synaptic vesicle exocytosis is regulated, and how the release machineries of classical and catecholaminergic neurotransmitters differ.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11520923     DOI: 10.1146/annurev.neuro.24.1.933

Source DB:  PubMed          Journal:  Annu Rev Neurosci        ISSN: 0147-006X            Impact factor:   12.449


  69 in total

Review 1.  Neural plate patterning by secreted signals.

Authors:  Oliver Wessely; E M De Robertis
Journal:  Neuron       Date:  2002-02-14       Impact factor: 17.173

2.  Glycerotoxin from Glycera convoluta stimulates neurosecretion by up-regulating N-type Ca2+ channel activity.

Authors:  Frédéric A Meunier; Zhong-Ping Feng; Jordi Molgó; Gerald W Zamponi; Giampietro Schiavo
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

3.  FLRT proteins are endogenous latrophilin ligands and regulate excitatory synapse development.

Authors:  Matthew L O'Sullivan; Joris de Wit; Jeffrey N Savas; Davide Comoletti; Stefanie Otto-Hitt; John R Yates; Anirvan Ghosh
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

Review 4.  Presynaptic frequency- and pattern-dependent filtering.

Authors:  Alex M Thomson
Journal:  J Comput Neurosci       Date:  2003 Sep-Oct       Impact factor: 1.621

Review 5.  Bioenergetics and transmitter release in the isolated nerve terminal.

Authors:  David G Nicholls
Journal:  Neurochem Res       Date:  2003-10       Impact factor: 3.996

6.  Nonsynaptic GABA signaling in postnatal subventricular zone controls proliferation of GFAP-expressing progenitors.

Authors:  Xiuxin Liu; Qin Wang; Tarik F Haydar; Angélique Bordey
Journal:  Nat Neurosci       Date:  2005-08-14       Impact factor: 24.884

7.  From the black widow spider to human behavior: Latrophilins, a relatively unknown class of G protein-coupled receptors, are implicated in psychiatric disorders.

Authors:  Ariel F Martinez; Maximilian Muenke; Mauricio Arcos-Burgos
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-12       Impact factor: 3.568

8.  alpha-Latrotoxin increases spontaneous and depolarization-evoked exocytosis from pancreatic islet beta-cells.

Authors:  Amelia M Silva; June Liu-Gentry; Adam S Dickey; David W Barnett; Stanley Misler
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

9.  Miniature synaptic events elicited by presynaptic Ca2+ rise are selectively suppressed by cannabinoid receptor activation in cerebellar Purkinje cells.

Authors:  Miwako Yamasaki; Kouichi Hashimoto; Masanobu Kano
Journal:  J Neurosci       Date:  2006-01-04       Impact factor: 6.167

10.  Latrophilin is required for toxicity of black widow spider venom in Caenorhabditis elegans.

Authors:  Christopher J Mee; Simon R Tomlinson; Pavel V Perestenko; David De Pomerai; Ian R Duce; Peter N R Usherwood; David R Bell
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.